Editas Medicine (EDIT) Operating Income (2016 - 2025)
Historic Operating Income for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$24.5 million.
- Editas Medicine's Operating Income rose 6261.69% to -$24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$198.8 million, marking a year-over-year increase of 1298.52%. This contributed to the annual value of -$251.2 million for FY2024, which is 4845.17% down from last year.
- As of Q3 2025, Editas Medicine's Operating Income stood at -$24.5 million, which was up 6261.69% from -$51.5 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Operating Income registered a high of -$24.0 million during Q4 2023, and its lowest value of -$76.2 million during Q1 2025.
- Moreover, its 5-year median value for Operating Income was -$51.5 million (2025), whereas its average is -$52.2 million.
- As far as peak fluctuations go, Editas Medicine's Operating Income plummeted by 53667.82% in 2021, and later skyrocketed by 6261.69% in 2025.
- Quarter analysis of 5 years shows Editas Medicine's Operating Income stood at -$41.6 million in 2021, then plummeted by 52.48% to -$63.4 million in 2022, then surged by 62.23% to -$24.0 million in 2023, then plummeted by 94.45% to -$46.6 million in 2024, then surged by 47.31% to -$24.5 million in 2025.
- Its Operating Income was -$24.5 million in Q3 2025, compared to -$51.5 million in Q2 2025 and -$76.2 million in Q1 2025.